Skip to main content
. 2021 Dec 13;10(12):1983. doi: 10.3390/antiox10121983

Table 2.

Serum and urine variables (mean ± standard deviation) of nondiabetic rats (NDR), diabetic control rats (DR), and DR treated with hydroxytyrosol (HT) 5 mg/kg/day p.o. (HT-5), 3′,4′-dihidroxifenilglicol (DHPG) 0.5 or 1 mg/kg/day p.o. (DHPG-0.5, DHPG-1), or their association. n = 10 rats per group.

Variable NDR DR HT-5 DHPG-0.5 DHPG-1 HT-5 + DHPG-0.5 HT-5 + DHPG-1
Blood glucose (mg/dL) 95.1 ± 5.3 456 ± 10.0 (+) 460 ± 9.7 384 ± 32.5 424 ± 36.7 329 ± 39.8 420 ± 10.8
Total cholesterol (mg/dL) 57.5 ± 7.4 78.7 ± 4.7 68.3 ± 2.5 75.2 ± 7.5 71.0 ± 9.1 70.7 ± 6.7 72.5 ± 4.7
LDL cholesterol (mg/dL) 23.2 ± 5.4 33.5 ± 5.8 30.1 ± 7.8 34.0 ± 6.8 29.2 ± 6.1 28.2 ± 7.1 27.7 ± 4.1
HDL cholesterol (mg/dL) 18.5 ± 2.4 18.4 ± 4.8 28.0 ± 8.1 (*) 25.5 ±5.4 27.5 ± 4.4 24.5 ± 4.1 25.2 ± 2.8
Triglycerides (mg/dL) 67.5± 7.7 105 ± 13.7 (+) 102 ± 6.6 108 ± 6.5 109 ± 13.5 85.5 ± 7.8 (*,a) 110 ± 7.4 (*)

+p < 0.05 with respect to NDR; * p < 0.05 with respect to DR; a p < 0.05 with respect to HT-5, DHPG-0.5 and DHPG-1.